Beer.Jk
PT. Bintang Toedjoe Tbk (BEER.JK) operates in the Food & Drug Retailing sector, primarily generating revenue through the production and distribution of alcoholic beverages, including beer and other related products.
Business. PT. Bintang Toedjoe Tbk (BEER.JK) operates in the Food & Drug Retailing sector, primarily generating revenue through the production and distribution of alcoholic beverages, including beer and other related products.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
PT. Bintang Toedjoe Tbk (BEER.JK) operates in the Food & Drug Retailing sector, primarily generating revenue through the production and distribution of alcoholic beverages, including beer and other related products.
The company's capital structure is characterized by a high level of equity, with total equity of IDR 233.9 billion, and a relatively low debt-to-equity ratio of 0.05, indicating a conservative leverage position. However, the company has negative net cash, as operating cash flow is negative at IDR -7.19 billion, and cash and equivalents are zero. This suggests potential liquidity constraints despite a strong current ratio of 14.88.
Profitability metrics show a return on equity (ROE) of 0.38% and a return on assets (ROA) of 0.35%, both of which are below the typical thresholds for healthy returns in the Food & Drug Retailing industry. The company's gross profit margin is 56.06%, and operating margin is 19.85%, which are in line with industry norms but do not indicate strong profitability.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segmental or geographic breakdown in the financial data limits the ability to assess risk distribution.
The company's growth trajectory is not clearly defined in the available data, as there are no forward-looking revenue projections or historical growth rates provided. The current year's revenue is IDR 36.01 billion, but without comparative data, it is difficult to assess the company's growth potential or performance relative to its peers.
The risk assessment indicates a medium liquidity risk due to negative net cash and a low dilution risk. The company's capital structure is relatively stable, but the negative operating cash flow and lack of cash reserves could pose challenges in the short term. No dilution adjustments were applied in the valuation, suggesting that the company has not issued additional shares recently.
There are no recent events or filings disclosed in the provided data that would indicate significant changes in the company's operations or financial position. The absence of recent transcripts or filings suggests a lack of transparency or public communication regarding the company's strategic direction or financial health.
- The company maintains a conservative capital structure with a low debt-to-equity ratio of 0.05.
- Profitability is weak, with ROE and ROA at 0.38% and 0.35%, respectively.
- The company lacks geographic and segmental diversification, increasing exposure to regional risks.
- Liquidity is a concern due to negative operating cash flow and zero cash reserves.
- No recent events or filings provide insight into the company's strategic direction.
Bull / Bear case
analysis pipelineIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- BEER.JK Market data — financials · 2026-05-27